Results 71 to 80 of about 3,885,108 (382)

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents [PDF]

open access: yesKorean Journal of Anesthesiology, 2017
Neuromuscular blockade plays an important role in the safe management of patient airways, surgical field improvement, and respiratory care. Rapid-sequence induction of anesthesia is indispensable to emergency surgery and obstetric anesthesia, and its ...
Yong Byum Kim   +2 more
doaj   +1 more source

A Wearable Ultra-Low-Power sEMG-Triggered Ultrasound System for Long-Term Muscle Activity Monitoring [PDF]

open access: yesarXiv, 2023
Surface electromyography (sEMG) is a well-established approach to monitor muscular activity on wearable and resource-constrained devices. However, when measuring deeper muscles, its low signal-to-noise ratio (SNR), high signal attenuation, and crosstalk degrade sensing performance.
arxiv  

Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy [PDF]

open access: yes, 2013
BACKGROUND: Spinal muscular atrophy (SMA) is a neuromuscular disease resulting from mutations in the survival motor neuron 1 (SMN1) gene. Recent breakthroughs in preclinical research have highlighted several potential novel therapies for SMA, increasing ...
Gillingwater, T. H.   +4 more
core   +3 more sources

Newcomb-Benford Law in Neuromuscular Transmission: Validation at Hyperkalemic Conditions [PDF]

open access: yesarXiv, 2023
Recently, we demonstrated the validity of anomalous numbers law, known as Newcomb-Benford's law, at the mammalian neuromuscular transmission, considering different extracellular calcium concentrations arXiv:2002.01986. The present work continues to examine how alterations in extracellular solution modulate the first digit law in the context of the ...
arxiv  

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease. [PDF]

open access: yes, 2017
BackgroundLate-onset Pompe disease is a rare genetic neuromuscular disorder caused by lysosomal acid alpha-glucosidase (GAA) deficiency that ultimately results in mobility loss and respiratory failure.
Barohn, Richard   +15 more
core   +2 more sources

Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists

open access: yesRevista Brasileira de Anestesiologia, 2016
BACKGROUND AND OBJECTIVES: residual paralysis following the use of neuromuscular blocking drugs (NMBDs) without neuromuscular monitoring remains a clinical problem, even when NMBDs are used.
Ismail Aytac   +7 more
doaj   +3 more sources

A comparison of the clinical duration and recovery characteristics of cisatracurium after priming using rocuronium or cisatracurium: preliminary study [PDF]

open access: yesKorean Journal of Anesthesiology, 2014
BackgroundThe priming technique can speed up the onset of cisatracurium during intubation. However, there have been no reports on the effect of the priming technique on duration or recovery profile of cisatracurium.
Ki Tae Jung   +3 more
doaj   +1 more source

Neuromuscular monitoring during anesthesia [PDF]

open access: yes, 2007
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open í sviðinuObjective: Muscle relaxants are very important in anesthetic practice but must be used with great care.
Erla G. Sveinsdóttir   +1 more
core  

Movement demands and perceived wellness associated with preseason training camp in NCAA Division I college football players [PDF]

open access: yes, 2017
The aims of this study were to examine the movement demands of preseason practice in National Collegiate Athletic Association Division I college football players using portable global positioning system (GPS) technology and to assess perceived wellness ...
Climstein, Mike   +4 more
core   +1 more source

ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This phase 3b, open‐label, randomized ADAPT NXT study investigated the efficacy, safety, and tolerability of efgartigimod administered in either a fixed cycles dosing regimen (3 cycles of 4 once‐weekly infusions, with 4 weeks between cycles) or a cycle followed by every‐other‐week (Q2W) dosing.
Ali A. Habib   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy